08045804946
Send Inquiry
BRYXTA 100MG INJ
3500.0 INR/Number
Product Details:
- Pacakaging (Quantity Per Box) 1 vial per box
- Origin of Medicine India
- Brand Name Bryxta
- Salt Composition Rituximab 100mg
- Indication Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis
- Life Span 24 months from manufacturing
- Dosage Form Injectable solution
- Click to View more
X
BRYXTA 100MG INJ Price And Quantity
- 3500.0 INR/Number
- 1 Number
- Clear to slightly opalescent
- 2 years
- Zydus Cadila
- L01XC02
- Cadila Healthcare Ltd
- WHO-GMP certified
- Yes
- Infusion-related reactions, infections, fever, chills, nausea
- Intravenous infusion
- 100mg/10ml
BRYXTA 100MG INJ Product Specifications
- Vial
- Injectable solution
- Injection
- Store at 2C to 8C. Do not freeze.
- Adults with Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis
- Cancer treatment and autoimmune disease management
- 24 months from manufacturing
- Adults
- India
- Bryxta
- Rituximab 100mg
- Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis
- As prescribed by the physician
- Biological
- Administer intravenously under medical supervision
- 1 vial of 10ml
- 1 vial per box
- Rituximab 100mg
- Clear to slightly opalescent
- 2 years
- Zydus Cadila
- L01XC02
- Cadila Healthcare Ltd
- WHO-GMP certified
- Yes
- Infusion-related reactions, infections, fever, chills, nausea
- Intravenous infusion
- 100mg/10ml
BRYXTA 100MG INJ Trade Information
- 1000 Number Per Week
- 2 Days
- No
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
- Active Ingredient: Bevacizumab 100 mg per 4 mL vial.
- Mechanism of Action: Bevacizumab works by binding to a protein called Vascular Endothelial Growth Factor (VEGF). VEGF normally promotes the growth of new blood vessels that supply oxygen and nutrients to tumors. By inhibiting VEGF, the medication cuts off the tumor's blood supply, causing it to shrink or stop growing and spreading.
- Uses: Bryxta 100mg is used to manage several types of advanced or metastatic cancers, including:
- Colorectal cancer
- Non-small cell lung cancer
- Kidney cancer (renal cell carcinoma)
- Cervical cancer
- Epithelial ovarian, fallopian tube, or primary peritoneal cancer
- Recurrent glioblastoma (brain tumor)
- Hepatocellular carcinoma (liver cancer)
- Storage: The injection should be stored in a refrigerator at 2C to 8C (36F to 46F) and protected from light. It must not be frozen
Targeted Therapy for Serious Conditions
BRYXTA 100MG INJ is formulated with Rituximab, offering targeted treatment for life-threatening cancers and autoimmune disorders like Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis in adults. Its mode of action helps in modulating the immune system or attacking malignant cells, improving patient outcomes significantly.
Quality and Safety Assurance
Produced under WHO-GMP certified facilities, BRYXTA meets stringent global safety and quality standards. The medication is packaged as a sterile vial and supplied by validated dealers and distributors throughout India, providing confidence to healthcare providers and patients alike.
Proper Usage and Administration
BRYXTA 100MG INJ must be administered as an intravenous infusion in a clinical setting under strict medical supervision. The dosage and frequency are tailored by the treating physician based on the severity of the disease and individual patient factors, ensuring both efficacy and patient safety.
FAQ's of BRYXTA 100MG INJ:
Q: How should BRYXTA 100MG INJ be administered?
A: BRYXTA 100MG INJ is given as an intravenous infusion by qualified healthcare professionals in a clinical or hospital setting, ensuring proper monitoring during administration.Q: What conditions is BRYXTA 100MG INJ recommended for?
A: BRYXTA is indicated for adults with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis, as directed by a physician.Q: When should BRYXTA 100MG INJ be used during treatment?
A: The timing and frequency of BRYXTA administration depend on the specific diagnosis and the physician's treatment protocol. It will be scheduled as per your individualized treatment plan.Q: Where should BRYXTA 100MG INJ be stored?
A: Store BRYXTA vials at temperatures between 2C and 8C. Do not freeze the product to maintain its efficacy and safety.Q: What possible side effects can occur with BRYXTA 100MG INJ?
A: Common side effects include infusion-related reactions such as fever, chills, nausea, and increased risk of infections. Immediately inform your medical team if these or other symptoms appear.Q: Who can benefit from BRYXTA 100MG INJ?
A: Adults diagnosed with the approved indications-Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Rheumatoid Arthritis-may benefit, as prescribed by their physician.Q: What is the process for obtaining BRYXTA 100MG INJ?
A: BRYXTA requires a valid prescription and is supplied through authorized dealers, distributors, or hospitals, ensuring patients receive genuine, safe, and effective medication.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
